Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.84
Delayed Data
As of May 26
 -0.06 / -0.61%
Today’s Change
8.75
Today|||52-Week Range
15.45
-5.29%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close9.90
Today’s open9.92
Day’s range9.79 - 10.13
Volume121,980
Average volume (3 months)150,230
Market cap$407.1M
Dividend yield--
Data as of 05/26/2017

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+679.17%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio16.4
Price/Sales2.86
Price/Book9.62

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.89-6.41%
MYOKMyoKardia Inc-0.20-1.55%
ARNAArena Pharmaceutical...-0.05-3.68%
NLNKNewLink Genetics Cor...-0.90-5.91%
Data as of 05/26/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Michael Shannon Anderson
CFO, Treasurer, Director &
CAO
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts